Novavax reaches settlement with UK Health Security Agency over COVID-19 vaccine agreement
Novavax to refund $123.8 million to UKHSA in quarterly payments through 2027
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
IIL develops needle-free intranasal COVID-19 booster vaccine
New vaccine developed in collaboration with Griffith University published in ‘Nature Communications’
FDA approves and authorises updated mRNA COVID-19 vaccines
The mRNA COVID-19 vaccines have been updated with a monovalent component that corresponds to the Omicron variant KP.2 strain…
FDA awards record number of review designations to mRNA vaccines in 2023: GlobalData
Following FDA approval in August 2021, Pfizer’s Comirnaty became the first mRNA vaccine to enter the global market, followed by…
Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)
mRESVIA is Moderna's second approved product and reportedly the only RSV vaccine available in single-dose pre-filled syringes …
Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study
This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of…
Affordability is tied to quality
In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…
China approves its first mRNA vaccine from CSPC
The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData
There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…
Rising costs forced patients to postpone or stop treatments in 2022: GlobalData
Compared to other researched markets (France, Germany, Italy, Spain, the UK and Japan), the US respondents reported the highest…